Skip to main content

Robotic-Assisted Versus Laparoscopic Revisional Roux-en-Y Gastric Bypass: A Systematic Review and Meta-Analysis

In brief

Robotic bypass linked to 35% lower odds of overall morbidity

In five retrospective studies totaling 27,341 patients, robotic revisional gastric bypass was associated with 35% lower odds of overall morbidity and 45% lower odds of needing treatment for bleeding than laparoscopic surgery. Other outcomes did not differ significantly, and both apparent benefits were sensitive to which studies were included; very low-certainty evidence leaves superiority unproven.

Journal
Obesity surgery (Q1)
Published
16 November 2026
Study design
Systematic review of cohort studies
Evidence level
Level 2, Moderate (CEBM 2a)
Authors
Felippe Furlan Kelher, Vitória Maia Corrêa, Fernanda de Moraes Nava, Lucas Monteiro Delgado, Cláudia Theis, Sérgio Mazzola Poli de Figueiredo, et al.
PMID
43035621
DOI
10.1007/s11695-026-09031-3

Why clinicians should know about it

  • Picked for Bariatric and Metabolic Surgery (top studies of the week, 22 November 2026): Directly compares robotic and laparoscopic revisional RYGB outcomes

Abstract

BACKGROUND: Robotic-assisted surgery has been increasingly adopted for complex revisional bariatric procedures, but whether it provides clinical advantages over conventional laparoscopy for revisional Roux-en-Y gastric bypass (RYGB) remains uncertain. This systematic review and meta-analysis aimed to provide an updated, procedure-specific synthesis of comparative evidence evaluating robotic-assisted versus laparoscopic revisional or conversional RYGB. METHODS: We searched PubMed/MEDLINE, Scopus, and CENTRAL from inception through August 2026 for comparative studies of adults undergoing robotic-assisted versus laparoscopic revisional or conversion RYGB. Random-effects meta-analyses were performed using odds ratios (ORs) for dichotomous outcomes and mean differences (MDs) for continuous outcomes, with 95% confidence intervals (CIs). Risk of bias and certainty of evidence were assessed using ROBINS-I and GRADE, respectively. RESULTS: Five retrospective comparative studies comprising 27,341 patients were included. Robotic-assisted surgery was associated with lower odds of overall morbidity (OR 0.65, 95% CI 0.43-1.00; p = 0.049; I2 = 20.9%). No statistically significant differences were observed in reoperation (OR 0.61, 95% CI 0.22-1.68), leak (OR 0.48, 95% CI 0.11-2.00), hemorrhage/bleeding (OR 0.73, 95% CI 0.31-1.72), mortality (OR 0.62, 95% CI 0.04-8.73), length of stay (MD - 0.71 days, 95% CI - 1.66 to 0.24), or operative time (MD 13.43 min, 95% CI - 28.24 to 55.11). Robotic surgery was also associated with lower odds of intervention for bleeding (OR 0.55, 95% CI 0.34-0.88; I2 = 0%). Both significant results were sensitive to study composition in leave-one-out analyses. Certainty of evidence was very low for all outcomes. CONCLUSIONS: Robotic-assisted revisional or conversional RYGB was associated with lower odds of overall morbidity and of intervention for bleeding, with no significant differences in the remaining outcomes, including comparable operative time. Both findings were borderline and sensitive to study composition, and the very low certainty of evidence precludes conclusions of superiority.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.